Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_assertion type Assertion NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_head.
- NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_assertion description "[In an attempt to elucidate the relationship between biomarkers of tumor hypoxia, glycolysis and angiogenesis, we tested the hypothesis that intratumoral gene expression of the hypoxia response (hypoxia inducible factor [HIF1 alpha and 2 alpha]), glycolysis (lactate dehydrogenase A [LDHA]), glucose metabolism (glucose transporter-1 [Glut-1]) and genes involved in angiogenesis (i.e., VEGFA, VEGFR1-3, and neuropilin [NRP]1) are upregulated in metastatic colorectal cancer (mCRC) patients with high serum lactate dehydrogenase (LDH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_provenance.
- NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_assertion evidence source_evidence_literature NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_provenance.
- NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_assertion SIO_000772 18086000 NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_provenance.
- NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_assertion wasDerivedFrom befree-20150227 NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_provenance.
- NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_assertion wasGeneratedBy ECO_0000203 NP695928.RAKT8JVR4xGz_tC5PmcI-hHeh-cGgahrLeZoMmV7-3N3c130_provenance.